Singaporean researchers discover that sialokinin, a peptide in Aedes mosquito saliva, binds neurokinin receptors to suppress early inflammation, facilitating chikungunya virus spread. Targeting salivary proteins could offer novel therapeutic strategies against CHIKV and other mosquito-borne viruses.
Sydney: Some therapies that are successful in treating rheumatoid arthritis (RA) may help improve treatment for people with debilitating mosquito-borne viral diseases, new research has found. Infection caused by Chikungunya virus (CHIKV) and Ross River virus (RRV) are transmitted by mosquitoes and cause severe arthritis, muscle pain and fever. “The disease caused by these viral […]
